Literature DB >> 20482313

Sprouty4 levels are increased under hypoxic conditions by enhanced mRNA stability and transcription.

Barbara Haigl1, Christoph-Erik Mayer, Gerald Siegwart, Hedwig Sutterlüty.   

Abstract

Sprouty (Spry) proteins are well-known negative regulators of receptor tyrosine kinase-mediated signalling. Their expression is controlled by mitogens, implying a negative feedback loop. Correspondingly, the different members of the family fulfil important roles during organogenesis by adjustment of growth factor-induced processes. In addition, Spry4, one member of this protein family, has been shown to regulate angiogenesis by inhibiting vascular endothelial cell growth factor-induced extracellular signalling-regulated kinase (ERK) activation. Because oxygen is an important regulator of angiogenesis, we investigated Spry4 expression patterns under hypoxic conditions. Our data demonstrate that both hypoxia and desferrioxamine (DFO) treatment increased Spry4 expression. Following iron depletion, elevated Spry4 levels were detected in several cell types independent of tissue origin, presence of mitogens, cell differentiation and malignancy. Evaluation of the underlying regulative mechanisms revealed that augmented transcription and increased mRNA stability enhance mRNA levels of Spry4 in response to DFO. This study unveils a growth factor-independent regulation mechanism of Spry4 expression. Because increased Spry4 levels are accompanied by disappearing ERK phosphorylation, Spry4 might be involved in the timely restriction of MAPK signals under hypoxic conditions, similar to its role in mitogen-regulated processes. However, the functional significance of the observed upregulation of Spry4 during iron depletion remains to be clarified.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20482313     DOI: 10.1515/BC.2010.082

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  15 in total

1.  Regulation of cellular levels of Sprouty2 protein by prolyl hydroxylase domain and von Hippel-Lindau proteins.

Authors:  Kimberly Anderson; Kyle A Nordquist; Xianlong Gao; Kristin C Hicks; Bo Zhai; Steven P Gygi; Tarun B Patel
Journal:  J Biol Chem       Date:  2011-10-17       Impact factor: 5.157

2.  Sprouty4 mRNA variants and protein expressions in breast and lung-derived cells.

Authors:  Angelina Doriguzzi; Jihen Salhi; Hedwig Sutterlüty-Fall
Journal:  Oncol Lett       Date:  2016-09-30       Impact factor: 2.967

3.  Spry1 as a novel regulator of erythropoiesis, EPO/EPOR target, and suppressor of JAK2.

Authors:  Pradeep Sathyanarayana; Arvind Dev; Anamika Pradeep; Melanie Ufkin; Jonathan D Licht; Don M Wojchowski
Journal:  Blood       Date:  2012-04-16       Impact factor: 22.113

4.  Insights into the Proteome of Gastrointestinal Stromal Tumors-Derived Exosomes Reveals New Potential Diagnostic Biomarkers.

Authors:  Safinur Atay; Daniel W Wilkey; Mohammed Milhem; Michael Merchant; Andrew K Godwin
Journal:  Mol Cell Proteomics       Date:  2017-12-14       Impact factor: 5.911

5.  HIF1A induces expression of the WASF3 metastasis-associated gene under hypoxic conditions.

Authors:  Pushpankur Ghoshal; Yong Teng; Leslie Ann Lesoon; John K Cowell
Journal:  Int J Cancer       Date:  2012-05-30       Impact factor: 7.396

6.  Overexpression of Aurora-A in primary cells interferes with S-phase entry by diminishing Cyclin D1 dependent activities.

Authors:  Florian Jantscher; Christine Pirker; Christoph-Erik Mayer; Walter Berger; Hedwig Sutterluety
Journal:  Mol Cancer       Date:  2011-03-16       Impact factor: 27.401

7.  Hypoxia inducible factors regulate the transcription of the sprouty2 gene and expression of the sprouty2 protein.

Authors:  Xianlong Gao; Kristin C Hicks; Paul Neumann; Tarun B Patel
Journal:  PLoS One       Date:  2017-02-14       Impact factor: 3.240

Review 8.  The developing story of Sprouty and cancer.

Authors:  Samar Masoumi-Moghaddam; Afshin Amini; David Lawson Morris
Journal:  Cancer Metastasis Rev       Date:  2014-09       Impact factor: 9.264

9.  MicroRNA-21 Increases Proliferation and Cisplatin Sensitivity of Osteosarcoma-Derived Cells.

Authors:  Vanita Vanas; Barbara Haigl; Verena Stockhammer; Hedwig Sutterlüty-Fall
Journal:  PLoS One       Date:  2016-08-11       Impact factor: 3.240

10.  Novel Function of Sprouty4 as a Regulator of Stemness and Differentiation of Embryonic Stem Cells.

Authors:  Jae-Young Lee; Sunghyun Park; Kwang-Soo Kim; Jeong-Jae Ko; Soohong Lee; Keun Pil Kim; Kyung-Soon Park
Journal:  Dev Reprod       Date:  2016-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.